Sep 20, 2022
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy
Read More
Sep 20, 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
Read More
Sep 19, 2022
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device
Read More
Sep 16, 2022
HAYA Therapeutics Appoints Brian C. Thomas, Ph.D., as Chairperson of the Board of Directors
Read More
Aug 22, 2022
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Read More
Jul 13, 2022
Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research
Read More